IJ
Program

Leveraging Europe's Expertise to accelerate Cell Therapy for Type 1 Diabetes

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

Innovative Health Initiative Joint Undertaking (IHI JU)EUGrant
About

This is a two-stage Research and Innovation Action, with a short proposal at the first deadline and a full proposal at the second if invited. The IHI JU expects to fund one project from this topic, worth close to EUR 8,825,000, drawn from a call budget of EUR 37,209,000 shared with three sibling topics in the same IHI Call 11.

Industries covered
BiotechMedtech
Grants under Leveraging Europe's Expertise to accelerate Cell Therapy for Type 1 Diabetes

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.

Leveraging Europe's Expertise to accelerate Cell Therapy for Type 1 Diabetes
Closed

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

€37.2M pool